Updated Jul 16, 2026
Verwiel Frank has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Verwiel Frank is an individual identified in SEC filings in connection with Intellia Therapeutics, Inc. as of June 10, 2026. Public biographical information about this person is not readily available in widely accessible sources, and their exact role (e.g., officer, director, or other insider) is not specified in the context provided. The name appears in association with Intellia Therapeutics’ SEC disclosures, but there is limited corroborating public biography beyond the filing context.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 9.2K | $0.00 |
Verwiel Frank is an individual identified in SEC filings in connection with Intellia Therapeutics, Inc. as of June 10, 2026. Public biographical information about this person is not readily available in widely accessible sources, and their exact role (e.g., officer, director, or other insider) is not specified in the context provided. The name appears in association with Intell…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Verwiel Frank profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.